Capricor and Johns Hopkins University Sign Licensing Deal for COVID-19 Test Platform’s IP and Know-How

shot by IP News Shots / 6:40 pm on 02 February, 2021

Capricor Therapeutics Inc. has entered into a licensing deal for the intellectual property, data and know-how of a COVID-19 serology test platform from Johns Hopkins University. Capricor will work towards the clinical development of the novel imaging-based serology test platform for COVID-19.

Read More at: https://seekingalpha.com/news/3656663-capricor-signs-intellectual-property-license-for-covid-19-serology-test-platform

Industry: Biotechnology | Type of IP: Deals - Licensing